返回 Agenda
Session 6 - Regulatory Reform and ICH implementation in Asian Countries
Session Chair(s)
Junko Sato, PHD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Regulatory Reform in National Medical Product Administration of China
Carol Zhu, MBA
JW Therapeutics, China
Vice President, Portfolio and Project Management
NMPA Regulatory Reform - Recent Challenges at Pharmaceutical Companies -
Tetsuomi Takano, RPH
Drug R&D Expert, Japan
Editor-in-Chief
Regulatory Reform and the ICH Implementation Status
Eun Kyung Kim
Ministry of Food and Drug Safety, Korea, Republic of
ICH Related Training by CORE
James Leong, PHD, MPHARM
Duke NUS Medical School, Singapore
Head,Health Products & Regulatory Science Centre of Regulatory Excellence (CoRE)